Refine
Year of publication
Document Type
- Preprint (653)
- Article (401)
- Conference Proceeding (1)
Language
- English (1055)
Has Fulltext
- yes (1055)
Is part of the Bibliography
- no (1055)
Keywords
- Heavy Ion Experiments (22)
- Hadron-Hadron scattering (experiments) (12)
- Hadron-Hadron Scattering (11)
- LHC (8)
- Heavy-ion collisions (6)
- Heavy Quark Production (5)
- Heavy-ion collision (5)
- Jets (5)
- Collective Flow (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Diffraction (3)
- Jets and Jet Substructure (3)
- Quarkonium (3)
- ALICE experiment (2)
- Beam Energy Scan (2)
- Chiral Magnetic Effect (2)
- Elastic scattering (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- HIV (2)
- Heavy-Ion Collision (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Quark Gluon Plasma (2)
- pp collisions (2)
- sphingolipid (2)
- 900 GeV (1)
- ALICE detector (1)
- ARDS (1)
- Alzheimer (1)
- Amyloid precursor protein (1)
- Analysis and statistical methods (1)
- Anti-nuclei (1)
- B-slope (1)
- Beam energy scan (1)
- Beauty production (1)
- Boosted Jets (1)
- Business strategy in drug development (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- COVID-19 (1)
- CVID (1)
- Calorimeters (1)
- Cell-to-Cell Spread (1)
- Charged-particle density (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Checkpoint inhibitor (1)
- Chiral magnetic effect (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Collective Flow, (1)
- Collectivity (1)
- Comparison with QCD (1)
- Compression stocking (1)
- Conservation biogeography (1)
- Correlation (1)
- Couch tracking (1)
- Critical care (1)
- Critical point (1)
- DHA (1)
- Data processing methods (1)
- Deep vein thrombosis (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Drug therapy (1)
- EPA (1)
- Early goal-directed therapy (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- European Society for Immunodeficiencies (ESID) (1)
- FAPI PET (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Fibrotest (1)
- Forward physics (1)
- Genetic wildlife monitoring (1)
- German PID-NET registry (1)
- Gimbaled tracking (1)
- Groomed jet radius (1)
- HBT (1)
- HCV (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hair sampling (1)
- Hard Scattering (1)
- Heavy Ion Experiment (1)
- Heavy Ions (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy-flavor decay electron (1)
- Heavy-ion detectors (1)
- Hepatotoxicity (1)
- Higher moments (1)
- IgG substitution therapy (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Intensive care unit (1)
- Interference fragmentation function (1)
- Ionisation energy loss (1)
- J/ψ suppression (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jet substructure (1)
- Knockout (1)
- LC–MS/MS (1)
- Large detector systems for particle and astroparticle physics (1)
- Liver cirrhosis (1)
- Liver enzymes (1)
- LncRNA (1)
- Lure sticks (1)
- MLC tracking (1)
- Material budget (1)
- Mid-rapidity (1)
- Mortality (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple parton interactions (1)
- Neural network (1)
- Neuronal morphology (1)
- Nkx2-5 (1)
- Noninvasive genetic sampling (1)
- Nuclear modification factor (1)
- Organ motion (1)
- Outcome (1)
- PID prevalence (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Pb–Pb collisions (1)
- Performance of High Energy Physics Detectors (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Proton-proton collisions (1)
- Proton–proton (1)
- Proton–proton collisions (1)
- Pulmonary embolism (1)
- QCD (1)
- Quark Deconfinement (1)
- Quark Production (1)
- RHIC (1)
- Relativistic heavy-ion collisions (1)
- Renal cell carcinoma (1)
- Robotic tracking (1)
- S1P (1)
- SR-BI (1)
- STAR (1)
- SVR (1)
- Sepsis-bundle (1)
- Sequence (1)
- Shear viscosity (1)
- Single electrons (1)
- Single muons (1)
- SoftDrop (1)
- Spine density (1)
- Splitting function (1)
- Systemic treatment (1)
- TR (1)
- Targeted therapy (1)
- Thermal model (1)
- Tracking (1)
- Transient elastography (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Transversity (1)
- Trigger (1)
- Tyrosine kinase inhibitor mTOR inhibition (1)
- Vector Boson Production (1)
- Venous thromboembolism (1)
- Wide rapidity coverage (1)
- Xenon-based gas mixture (1)
- allogeneic stem cell transplantation (1)
- angiopoietin-like 3 (ANGPTL3) (1)
- biomarker (1)
- cART (1)
- ceramide (1)
- children (1)
- co-infection (1)
- dE/dx (1)
- detector (1)
- direct-acting antivirals (1)
- experimental results (1)
- fear conditioning (1)
- fibrosis imaging (1)
- heavy ion experiments (1)
- heavy-ion collisions (1)
- hepatic fibrosis (1)
- hepatitis C (1)
- hepatitis C virus (1)
- hypertrophy (1)
- immune reconstitution (1)
- insulin resistance (1)
- learning (1)
- mechanical accuracy (1)
- medial prefrontal cortex (mPFC) (1)
- memory consolidation and extinction (1)
- nuclear cardiology (1)
- oxLDL (1)
- p+p collisions (1)
- patient (1)
- phantom study (1)
- primary immunodeficiency (PID) (1)
- quark gluon plasma (1)
- registry for primary immunodeficiency (1)
- robot-guided stereotaxy (1)
- spectra (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- trans (1)
- transcranial magnetic stimulation (TMS) (1)
- ulcerative colitis (1)
- Υ suppression (1)
- √sN N = 2.76 TeV (1)
Institute
- Frankfurt Institute for Advanced Studies (FIAS) (953)
- Physik (935)
- Informatik (830)
- Medizin (23)
- Informatik und Mathematik (3)
- Georg-Speyer-Haus (2)
- Geowissenschaften (2)
- Biochemie und Chemie (1)
- Biowissenschaften (1)
- Hochschulrechenzentrum (1)
Introduction: Recommendations for venous thromboembolism and deep venous thrombosis (DVT) prophylaxis using graduated compression stockings (GCS) is historically based and has been critically examined in current publications. Existing guidelines are inconclusive as to recommend the general use of GCS.
Patients/Methods: 24 273 in-patients (general surgery and orthopedic patients) undergoing surgery between 2006 and 2016 were included in a retrospectively analysis from a single center. From January 2006 to January 2011 perioperative GCS was employed additionally to drug prophylaxis and from February 2011 to March 2016 patients received drug prophylaxis alone. According to german guidelines all patients received venous thromboembolism prophylaxis with weight-adapted LMWH. Risk stratification (low risk, moderate risk, high risk) was based on the guideline of the American College of Chest Physicians. Data analysis was performed before and after propensity matching (PM). The defined primary endpoint was the incidence of symptomatic or fatal pulmonary embolism (PE). A secondary endpoint was the incidence of deep venous thromboembolism (DVT).
Results: After risk stratification (low risk n = 16 483; moderate risk n = 4464; high risk n = 3326) a total of 24 273 patient were analyzed. Before to PM the relative risk for the occurrence of a PE or DVT was not increased by abstaining from GCS. After PM two groups of 11 312 patients each, one with and one without GCS application, were formed. When comparing the two groups, the relative risk (RR) for the occurrence of a pulmonary embolism was: Low Risk 0.99 [CI95% 0.998–1.000]; Moderate Risk 0.999 [CI95% 0.95–1.003]; High Risk 0.996 [CI95% 0.992–1.000] (p > 0.05). The incidence of PE in the total group LMWH alone was 0.1% (n = 16). In the total group using LMWH + GCS, the incidence was 0.3% (n = 29). RR after PM was 0.999 [CI95% 0.998–1.00].
Conclusion: In comparison to prior studies with only small numbers of patients our trial shows in a large group of patients with moderate and high risk developing VTE we can support the view that abstaining from GCS-use does not increase the incidence of symptomatic or fatal PE and symptomatic DVT.
Background: Epileptic seizures are common clinical features in patients with acute subdural hematoma (aSDH); however, diagnostic feasibility and therapeutic monitoring remain limited. Surface electroencephalography (EEG) is the major diagnostic tool for the detection of seizures but it might be not sensitive enough to detect all subclinical or nonconvulsive seizures or status epilepticus. Therefore, we have planned a clinical trial to evaluate a novel treatment modality by perioperatively implanting subdural EEG electrodes to diagnose seizures; we will then treat the seizures under therapeutic monitoring and analyze the clinical benefit.
Methods: In a prospective nonrandomized trial, we aim to include 110 patients with aSDH. Only patients undergoing surgical removal of aSDH will be included; one arm will be treated according to the guidelines of the Brain Trauma Foundation, while the other arm will additionally receive a subdural grid electrode. The study's primary outcome is the comparison of incidence of seizures and time-to-seizure between the interventional and control arms. Invasive therapeutic monitoring will guide treatment with antiseizure drugs (ASDs). The secondary outcome will be the functional outcome for both groups as assessed via the Glasgow Outcome Scale and modified Rankin Scale both at discharge and during 6 months of follow-up. The tertiary outcome will be the evaluation of chronic epilepsy within 2-4 years of follow-up.
Discussion: The implantation of a subdural EEG grid electrode in patients with aSDH is expected to be effective in diagnosing seizures in a timely manner, facilitating treatment with ASDs and monitoring of treatment success. Moreover, the occurrence of epileptiform discharges prior to the manifestation of seizure patterns could be evaluated in order to identify high-risk patients who might benefit from prophylactic treatment with ASDs.
Trial registration: ClinicalTrials.gov identifier no. NCT04211233.
After myocardial infarction in the adult heart the remaining, non-infarcted tissue adapts to compensate the loss of functional tissue. This adaptation requires changes in gene expression networks, which are mostly controlled by transcription regulating proteins. Long non-coding transcripts (lncRNAs) are now recognized for taking part in fine-tuning such gene programs. We identified and characterized the cardiomyocyte specific lncRNA Sweetheart RNA (Swhtr), an approximately 10 kb long transcript divergently expressed from the cardiac core transcription factor coding gene Nkx2-5. We show that Swhtr is dispensable for normal heart development and function, but becomes essential for the tissue adaptation process after myocardial infarction. Re-expressing Swhtr from an exogenous locus rescues the Swhtr null phenotype. Genes depending on Swhtr after cardiac stress are significantly occupied, and therefore most likely regulated by NKX2-5. Our results indicate a synergistic role for Swhtr and the developmentally essential transcription factor NKX2-5 in tissue adaptation after myocardial injury.
After myocardial infarction in the adult heart the remaining, non-infarcted tissue adapts to compensate the loss of functional tissue. This adaptation requires changes in gene expression networks, which are mostly controlled by transcription regulating proteins. Long non-coding transcripts (lncRNAs) are taking part in fine-tuning such gene programs. We describe and characterize the cardiomyocyte specific lncRNA Sweetheart RNA (Swhtr), an approximately 10 kb long transcript divergently expressed from the cardiac core transcription factor coding gene Nkx2-5. We show that Swhtr is dispensable for normal heart development and function but becomes essential for the tissue adaptation process after myocardial infarction in murine males. Re-expressing Swhtr from an exogenous locus rescues the Swhtr null phenotype. Genes that depend on Swhtr after cardiac stress are significantly occupied and therefore most likely regulated by NKX2-5. The Swhtr transcript interacts with NKX2-5 and disperses upon hypoxic stress in cardiomyocytes, indicating an auxiliary role of Swhtr for NKX2-5 function in tissue adaptation after myocardial injury.